Skip to content. | Skip to navigation

IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.



The Australian Familial Pancreatic Cancer Cohort is designed to explore the inherited aspects of pancreatic cancer

Australian Familial Pancreatic Cancer Cohort

The Australian Familial Pancreatic Cancer Cohort (AFPaCC) is a registry for individuals or families who have multiple relatives affected by pancreatic cancer. It is estimated that 5-10% of all pancreatic cancers are hereditary.

Read More…

Request to join AFPaCC

If you have a family history of pancreatic cancer, you may be eligible to join the Australian Familial Pancreatic Cancer Cohort (AFPaCC). Contact the clinical coordinator using the form below, to find out how you can be a part of this important research.

Read More…

Pancreatic Cancer Screening Trial

The first Australian pancreatic cancer screening trial is recruiting at St Vincent's Hospital, Sydney and Austin Health, Melbourne. The aim of the study is to assess endoscopic ultrasound (EUS) as a screening method in a population considered to be at increased risk of developing pancreatic cancer.

Read More…